Skip to main content
Thomas Povsic, MD, Cardiology, Durham, NC, Duke University Hospital

ThomasPovsicMD

Cardiology Durham, NC

Interventional Cardiology, Clinical Pharmacology

Professor, Medicine, Duke Clinical Research Institute, Duke University School of Medicine

Dr. Povsic is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Povsic's full profile

Already have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Interventional Cardiology, 2003 - 2004
  • Duke University Hospital
    Duke University HospitalFellowship, Cardiovascular Disease, 1998 - 2001
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1995 - 1998
  • Harvard Medical School
    Harvard Medical SchoolClass of 1995

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1997 - 2024
  • VA State Medical License
    VA State Medical License 1999 - 2008
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • BioCardia Announces First Patient Treated in CardiAMP Cell Therapy Trial for Chronic Myocardial Ischemia
    BioCardia Announces First Patient Treated in CardiAMP Cell Therapy Trial for Chronic Myocardial IschemiaOctober 21st, 2021
  • XyloCor Therapeutics Commences Phase 2 Component of Phase 1/2 EXACT Clinical Study of XC001 Gene Therapy for Refractory Angina
    XyloCor Therapeutics Commences Phase 2 Component of Phase 1/2 EXACT Clinical Study of XC001 Gene Therapy for Refractory AnginaJuly 27th, 2021
  • Access Denied: Stem Cell Therapy Shows Some Promise in Refractory Angina, but Patients Can’t Get It
    Access Denied: Stem Cell Therapy Shows Some Promise in Refractory Angina, but Patients Can’t Get ItMay 19th, 2017
  • Join now to see all

Grant Support

  • Assessing Circulating Progenitor Cells In Heart DiseaseNational Heart, Lung, And Blood Institute2006–2007

Hospital Affiliations